Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection

Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact o...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2018-05, Vol.217 (11), p.1793-1797
Main Authors: Stefic, Karl, Novelli, Sophie, Mahjoub, Nadia, Seng, Remonie, Molina, Jean-Michel, Cheneau, Christine, Barin, Francis, Chaix, Marie-Laure, Meyer, Laurence, Delaugerre, Constance
Format: Article
Language:English
Subjects:
Adult
Anti-HIV Agents - therapeutic use
Antiretroviral Therapy, Highly Active - methods
Female
HIV Antibodies - immunology
HIV Infections - drug therapy
HIV Infections - immunology
HIV-1 - drug effects
HIV-1 - immunology
Humans
Male
Point-of-Care Testing
Sustained Virologic Response
Viral Load - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact of early antiretroviral treatment (ART) on human immunodeficiency virus (HIV) antibody detection by rapid tests in 44 individuals after several years of successful ART. HIV self-tests and point-of-care tests were negative in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care.
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jiy120